These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 22245330)

  • 1. Chemokine and chemokine receptor expression in kidney tumors: molecular profiling of histological subtypes and association with metastasis.
    Gahan JC; Gosalbez M; Yates T; Young EE; Escudero DO; Chi A; Garcia-Roig M; Satyanarayana R; Soloway MS; Bird VG; Lokeshwar VB
    J Urol; 2012 Mar; 187(3):827-33. PubMed ID: 22245330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of clear cell renal cell carcinoma and oncocytoma using a three-gene promoter methylation panel.
    Pires-Luís AS; Costa-Pinheiro P; Ferreira MJ; Antunes L; Lobo F; Oliveira J; Henrique R; Jerónimo C
    J Transl Med; 2017 Jun; 15(1):149. PubMed ID: 28662726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stromal derived factor-1 (SDF-1) and its receptors CXCR4 and CXCR7 in endometrial cancer patients.
    Walentowicz-Sadlecka M; Sadlecki P; Bodnar M; Marszalek A; Walentowicz P; Sokup A; Wilińska-Jankowska A; Grabiec M
    PLoS One; 2014; 9(1):e84629. PubMed ID: 24416254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A negative-feedback loop maintains optimal chemokine concentrations for directional cell migration.
    Lau S; Feitzinger A; Venkiteswaran G; Wang J; Lewellis SW; Koplinski CA; Peterson FC; Volkman BF; Meier-Schellersheim M; Knaut H
    Nat Cell Biol; 2020 Mar; 22(3):266-273. PubMed ID: 32042179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mass Spectrometry Imaging Enables Discrimination of Renal Oncocytoma from Renal Cell Cancer Subtypes and Normal Kidney Tissues.
    Zhang J; Li SQ; Lin JQ; Yu W; Eberlin LS
    Cancer Res; 2020 Feb; 80(4):689-698. PubMed ID: 31843980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between chemokine/chemokine receptor and glioma prognosis and outcomes: Systematic review and meta-analysis.
    Yang S; Luo M; Yang S; Yuan M; Zeng H; Xia J; Wang N
    Int Immunopharmacol; 2024 May; 133():112047. PubMed ID: 38631221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High co-expression of the SDF1/CXCR4 axis in hepatocarcinoma cells is regulated by AnnexinA7 in vitro and in vivo.
    Wang J; Huang Y; Zhang J; Xing B; Xuan W; Wang H; Huang H; Yang J; Tang J
    Cell Commun Signal; 2018 May; 16(1):22. PubMed ID: 29783989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An emerging paradigm of CXCL12 involvement in the metastatic cascade.
    Anastasiadou DP; Quesnel A; Duran CL; Filippou PS; Karagiannis GS
    Cytokine Growth Factor Rev; 2024 Feb; 75():12-30. PubMed ID: 37949685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generation and dynamics of an endogenous, self-generated signaling gradient across a migrating tissue.
    Venkiteswaran G; Lewellis SW; Wang J; Reynolds E; Nicholson C; Knaut H
    Cell; 2013 Oct; 155(3):674-87. PubMed ID: 24119842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemokine receptor CXCR4 expression and prognosis in patients with metastatic prostate cancer.
    Akashi T; Koizumi K; Tsuneyama K; Saiki I; Takano Y; Fuse H
    Cancer Sci; 2008 Mar; 99(3):539-42. PubMed ID: 18201276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Comprehensive Analysis of CXCL12 Isoforms in Breast Cancer
    Zhao S; Chang SL; Linderman JJ; Feng FY; Luker GD
    Transl Oncol; 2014 May; 7(3):429-38. PubMed ID: 24836649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Absolute quantitative proteomics using the total protein approach to identify novel clinical immunohistochemical markers in renal neoplasms.
    Jorge S; Capelo JL; LaFramboise W; Satturwar S; Korentzelos D; Bastacky S; Quiroga-Garza G; Dhir R; Wiśniewski JR; Lodeiro C; Santos HM
    BMC Med; 2021 Sep; 19(1):196. PubMed ID: 34482820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic Significance of Tumor-Associated Inflammation in Renal Cell Carcinoma.
    Kovaleva OV; Podlesnaya PA; Mochalnikova VV; Kushlinskii NE; Khromykh LM; Kalinina AA; Kazansky DB; Gratchev AN
    Bull Exp Biol Med; 2024 Jan; 176(3):382-385. PubMed ID: 38340200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of the Hippo/YAP axis by CXCR7 in the tumorigenesis of gastric cancer.
    Wang T; Wang D; Sun Y; Zhuang T; Li X; Yang H; Zang Y; Liu Z; Yang P; Zhang C; Cui J; Fu M; Zhang S; Su P; Li Z; Zhu J; Ding Y
    J Exp Clin Cancer Res; 2023 Nov; 42(1):297. PubMed ID: 37950281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of AKI signatures and classification patterns in ccRCC based on machine learning.
    Wang L; Peng F; Li ZH; Deng YF; Ruan MN; Mao ZG; Li L
    Front Med (Lausanne); 2023; 10():1195678. PubMed ID: 37293297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cellular crosstalk of glomerular endothelial cells and podocytes in diabetic kidney disease.
    Jiang S; Luo M; Bai X; Nie P; Zhu Y; Cai H; Li B; Luo P
    J Cell Commun Signal; 2022 Sep; 16(3):313-331. PubMed ID: 35041192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential Expression of the Androgen Receptor, Splice Variants and Relaxin 2 in Renal Cancer.
    Bialek J; Piwonka M; Kawan F; Fornara P; Theil G
    Life (Basel); 2021 Jul; 11(8):. PubMed ID: 34440475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Role of CXCL12 in Kidney Diseases: A Friend or Foe?
    Song A; Jiang A; Xiong W; Zhang C
    Kidney Dis (Basel); 2021 May; 7(3):176-185. PubMed ID: 34179113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CXCL12γ induces human prostate and mammary gland development.
    Jung Y; Kim JK; Lee E; Cackowski FC; Decker AM; Krebsbach PH; Taichman RS
    Prostate; 2020 Sep; 80(13):1145-1156. PubMed ID: 32659025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A chemokine/chemokine receptor signature potentially predicts clinical outcome in colorectal cancer patients.
    Mitchell A; Hasanali SL; Morera DS; Baskar R; Wang X; Khan R; Talukder A; Li CS; Manoharan M; Jordan AR; Wang J; Bollag RJ; Singh N; Albo D; Ghosh S; Lokeshwar VB
    Cancer Biomark; 2019; 26(3):291-301. PubMed ID: 31524146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.